95 results
Page 3 of 5
8-K
EX-99.1
o07ud
26 May 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
ur3p1slyd
25 Feb 21
Regulation FD Disclosure
7:01am
424B3
k1ko as1ysjgt
27 Jan 21
Prospectus supplement
8:41am
424B5
wemd h1l8fzka2e
20 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
8j0cd5ypli 64az
19 Jan 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
aqfspsbxmq 6xa
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
43o4qs4
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
8-K
qrzk4
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
424B5
f2413lq3s6wyn6y69
23 Jun 20
Prospectus supplement for primary offering
5:16pm
424B5
ncdznko
6 Mar 20
Prospectus supplement for primary offering
5:30pm